Großes Pharmaunternehmen -> Biotech AI Startup

A large pharmaceutical company is in talks to acquire a biotech startup specializing in AI-driven drug discovery for around $900 million. The startup recently completed a successful Series B round. The acquisition would expand the pharma company's AI research capabilities in drug discovery.

AI-generated: summaries written by AI from the linked sources. How we use AI